Wegovy Pill weight loss in Ireland

Most people notice a reduction in appetite during weeks 5-8 as the dose increases to 4 mg. Measurable, consistent weight loss typically builds from week 8 onwards. The strongest results come at and after the 25 mg maintenance dose - usually from week 16+. In clinical trials, participants achieved an average of 16.6% weight loss over 64 weeks. Individual results vary.

The most common side effects are gastrointestinal: nausea, diarrhoea, constipation, vomiting, bloating, and stomach discomfort. These are usually mild to moderate and tend to improve as your body adjusts - particularly when doses are increased gradually through the titration schedule. Your Everwell prescriber can advise on strategies to manage them.

Nausea is the most commonly reported side effect, especially in the first few weeks or after a dose increase. It helps to eat smaller, lower-fat meals, avoid lying down immediately after eating, stay well hydrated, eat slowly, and avoid foods that are very rich, spicy, or greasy. Most people find nausea improves significantly within a few weeks. If it's persistent or severe, speak to your Everwell doctor - a slower titration may be recommended.

Seek medical attention immediately if you experience severe or persistent abdominal pain (possible pancreatitis), yellowing of the skin or eyes (possible gallbladder or liver issue), rapid or irregular heartbeat, symptoms of a serious allergic reaction (facial swelling, difficulty breathing), or severe and prolonged vomiting or diarrhoea. These are rare, but it's important to act quickly if they occur.

Alcohol isn't strictly contraindicated, but it can worsen nausea - a common early side effect - and tends to undermine weight management goals. Alcohol is calorie-dense, can impair food choices, and may irritate the stomach. It's best to minimise alcohol intake during your programme. Your clinician can advise based on your personal situation.

The Wegovy Pill is designed for long-term use as part of an ongoing weight management programme. Most clinical guidelines consider it a chronic treatment. Your prescriber will regularly review whether treatment is still appropriate and working well for you.

If you miss your morning dose but remember later the same day, you can take it - provided you still follow the correct instructions (empty stomach, small glass of plain water, 30-minute wait before eating). If you miss a full day, skip it and resume the next morning as normal. Never take two doses to make up for a missed one.

The Wegovy Pill is licensed for weight management in adults without type 2 diabetes. A different oral semaglutide product - Rybelsus - is approved for type 2 diabetes management. If you have type 2 diabetes and are interested in GLP-1 treatment for weight management, your Everwell doctor can advise on the most appropriate option for you.

Weight regain after stopping the Wegovy Pill is common, because the medication's appetite-suppressing effects stop too. This is why the lifestyle habits you build during your Everwell programme are so important - they help you sustain your results. Your team will support you in planning a long-term strategy.

Yes - the Wegovy Pill is prescribed alongside a reduced-calorie diet and increased physical activity. That's both the clinical recommendation and the foundation of the Everwell programme. Exercise improves your results, helps preserve muscle mass during weight loss, and supports long-term health. Your Everwell health coach will help you build a sustainable activity plan.

No. The Wegovy Pill should not be used if you are trying to become pregnant, are pregnant, or are breastfeeding. Women of childbearing age should use effective contraception during treatment. Due to semaglutide's long half-life, it's recommended to stop treatment before attempting to conceive - speak to your Everwell doctor for personalised advice on timing.

Both contain semaglutide - the same active ingredient. The key difference is how they're taken: the pill is swallowed once daily in the morning on an empty stomach, while the injection is self-administered under the skin once a week. Clinical data suggests the 25 mg oral pill may produce greater average weight loss than the 2.4 mg injection dose - though these results are from separate trials and cannot be directly compared. The pill is ideal for people who prefer to avoid needles.

Switching between weight management medications is possible, but it's not a simple like-for-like swap - dosing schedules differ and your current response, side effect history, and medical profile all need to be considered. If you're interested in switching to the Wegovy Pill, book a review with your Everwell clinical team to discuss your options.

The Wegovy Pill and Rybelsus both contain oral semaglutide and share a similar formulation. The key difference is their licensed indication: Rybelsus is approved for managing type 2 diabetes, while the Wegovy Pill is specifically approved for chronic weight management in people without type 2 diabetes. They are distinct, separately licensed medicines prescribed for different purposes.